Research Article
BibTex RIS Cite
Year 2023, , 59 - 66, 30.06.2023
https://doi.org/10.7197/cmj.1316057

Abstract

References

  • 1. Appel GB, Silva FG, Pirani CL, Meltzer JI, Estes D. Renal involvement in systemic lupud erythematosus (SLE): A study of 56 patients emphasizing histologic classification. Medicine 1978; 57: 371–410.
  • 2. Whittier WL, Korbet SM. Renal biopsy: update. Curr Opin Nephrol Hypertens. 2004; 13: 661-65. 3. Korbet SM. Percutaneous renal biopsy. Semin Nephrol 2002; 22(03): 254–67.
  • 4. Kajawo S, Moloi MW, Noubiap JJ, Ekrikpo U, Kengne AP, Okpechi IG. Incidence of major complications after percutaneous native renal biopsies in adults from low-income to middle in come countries: a protocol for systematic review and meta-analysis. BMJ Open 2018; 8(4): e020891.
  • 5. Trajceska L, Andreevska GS, Vidimliski PD, Nikolov I, Selim G, Spasovski G, et al. Complications and Risks of Percutaneous Renal Biopsy. Macedonian Journal of Medical Sciences 2019; 7(6): 992-95.
  • 6. Constantin A, Brisson ML, Kwan J, Proulx F. Percutaneous US-guided renal biopsy: a retrospective study comparing the 16-gauge end-cut and 14-gauge side-notch needles. J Vasc Interv Radiol 2010; 21: 357–61.
  • 7. J. Hogan J, Mocanu M, Berns JS. The Native Kidney Biopsy: Update and Evidence for Best Practice. Clin J Am Soc Nephrol 2016; 11(2): 354-62.
  • 8. Kim D, Kim H, Shin G, et al. A randomized, prospective, comparative study of manual and automated renal biopsies. Am J Kidney Dis 1998; 32: 426–31. 9.Amoueian S, Attaranzadeh A. Renal Biopsy Interpretation: In Topics in Renal Biopsy and Pathology. Edited by Mubarak M. Croatia: InTech, 2012: 45–64. 10.Gauthier BG, Mahadeo RS, Trachtman H. Techniques for percutaneous renal biopsies. Pediatr Nephrol 1993; 7: 457–63. 11. Sharma SG, Arthur JM, Bonsib SM, et al. An integrated pathology and ultrasonography based simulation for training in performing kidney biopsy. Clinical Nephrology 2018; 89(3): 214-22. 12.Esposito V, Mazzon G, Baiardi P, et al. Safety and adequacy of percutaneous kidney biopsy performed by nephrology trainees. BMC Nephrology 2018; 19: 14.
  • 13.Reschen ME, Mazzella A, Sharples E. A retrospective analysis of the utility and safety of kidney transplant biopsies by nephrology trainees and consultants. Annals of Medicine and Surgery 2018; 28: 6–10. 14.Lees JS, McQuarrie EP, Mordi N, Geddes CC, Fox JG, Mackinnon B. Risk factors for bleeding complications after nephrologist-performed native renal biopsy. Clinical Kidney Journal 2017; 10(4): 573–77.
  • 15.Ferrer G, Andeen NK, Lockridge J, et al. Kidney Biopsy Adequacy. Am J Surg Pathol 2019; 43: 84–92.
  • 16.Nass K, O’Neill WC. Bedside renal biopsy: ultrasound guidance by the nephrologist. Am J Kidney Dis 1999; 34: 955–59.
  • 17.Korbet SM,Volpini KC, Whittier WL. Percutaneous renal biopsy of native kidneys: A single-center experience of 1,055 biopsies. Am J Nephrol 2014; 39: 153–62.
  • 18.Racusen LC, Solez K, Colvin RB, et al. The Banff 97 working classification of renal allograft pathology Kidney Int 1999; 55(2): 713-23.
  • 19.Geldenhuys L, Nicholson P, Sinha N, et al. Percutaneous native renal biopsy adequacy: a successful interdepartmental quality improvement activity. Can J Kidney Health Dis 2015; 2: 8.
  • 20.Ali H, Murtaza A, Anderton J, Ahmed A. Post renal biopsy complication rate and diagnostic yield comparing hands free (ultrasound-assisted) and ultrasound-guided biopsy techniques of renal allografts and native. SpringerPlus 2015; 4(1): 491.
  • 21.Monahan H, Gunderson T, Greene E, Schmit G, Atwell T, Schmitz J. Risk factors associated with significant bleeding events after ultrasound‑guided percutaneous native renal biopsies: a review of 2204 case. Abdominal Radiology 2019; 44: 2316–32.
  • 22.Shin J, Park SY. Diagnostic efficacy and safety of ultrasound-guided kidney transplant biopsy using cortex-only view: a retrospective single-center study. European Radiology 2019; 29: 5272–79.

How does the presence of the pathologist affect the tissue adequacy and what are the factors affecting the pathologist in proficiency assessment, during percutaneous kidney biopsy?

Year 2023, , 59 - 66, 30.06.2023
https://doi.org/10.7197/cmj.1316057

Abstract

Objectives: For optimal histomorphological examination, adequacy of kidney biopsy tissue
should be obtained. In this study, the effect of a pathologist informing the radiologist about
tissue adequacy during the biopsy procedure on obtaining tissue adequacy was examined.
Furthermore, we aimed to determine the criteria that the pathologist considered in determining
tissue adequacy and the conditions affecting the decision to increase the number of core
biopsies, as these have not been previously examined in the literature.
Materials and Methods: Tissues containing less than 10 glomeruli were considered
inadequate. In some patients, a pathologist accompanied the radiologist during the procedure.
Tissue adequacy ratios and biopsy sample numbers were calculated between the two
conditions. In the samples taken with the pathologist, the factors affecting the locality
decision of the pathologist (cortex/medulla amount, presence of glomerular pathology(global,
segmental, crescentic glomeruli) presence of tubular injury, proteinuria; interstitial
inflammation and interstitial fibrosis/tubular atrophy ratios, account of normal glomeruli)
were examined.
Results: Giving tissue adequacy information during the biopsy procedure had a positive
effect on tissue adequacy. The amount of cortex is one of the qualification criteria for the
pathologist. The presence of proteinuria and 50% or more inflammation in tissues with
sufficient cortex increased the number of biopsy samples.

Conclusion: Determination of tissue adequacy during kidney biopsy is an important and
necessary method. The amount of cortex is one of the important parameters in tissue
adequacy.

References

  • 1. Appel GB, Silva FG, Pirani CL, Meltzer JI, Estes D. Renal involvement in systemic lupud erythematosus (SLE): A study of 56 patients emphasizing histologic classification. Medicine 1978; 57: 371–410.
  • 2. Whittier WL, Korbet SM. Renal biopsy: update. Curr Opin Nephrol Hypertens. 2004; 13: 661-65. 3. Korbet SM. Percutaneous renal biopsy. Semin Nephrol 2002; 22(03): 254–67.
  • 4. Kajawo S, Moloi MW, Noubiap JJ, Ekrikpo U, Kengne AP, Okpechi IG. Incidence of major complications after percutaneous native renal biopsies in adults from low-income to middle in come countries: a protocol for systematic review and meta-analysis. BMJ Open 2018; 8(4): e020891.
  • 5. Trajceska L, Andreevska GS, Vidimliski PD, Nikolov I, Selim G, Spasovski G, et al. Complications and Risks of Percutaneous Renal Biopsy. Macedonian Journal of Medical Sciences 2019; 7(6): 992-95.
  • 6. Constantin A, Brisson ML, Kwan J, Proulx F. Percutaneous US-guided renal biopsy: a retrospective study comparing the 16-gauge end-cut and 14-gauge side-notch needles. J Vasc Interv Radiol 2010; 21: 357–61.
  • 7. J. Hogan J, Mocanu M, Berns JS. The Native Kidney Biopsy: Update and Evidence for Best Practice. Clin J Am Soc Nephrol 2016; 11(2): 354-62.
  • 8. Kim D, Kim H, Shin G, et al. A randomized, prospective, comparative study of manual and automated renal biopsies. Am J Kidney Dis 1998; 32: 426–31. 9.Amoueian S, Attaranzadeh A. Renal Biopsy Interpretation: In Topics in Renal Biopsy and Pathology. Edited by Mubarak M. Croatia: InTech, 2012: 45–64. 10.Gauthier BG, Mahadeo RS, Trachtman H. Techniques for percutaneous renal biopsies. Pediatr Nephrol 1993; 7: 457–63. 11. Sharma SG, Arthur JM, Bonsib SM, et al. An integrated pathology and ultrasonography based simulation for training in performing kidney biopsy. Clinical Nephrology 2018; 89(3): 214-22. 12.Esposito V, Mazzon G, Baiardi P, et al. Safety and adequacy of percutaneous kidney biopsy performed by nephrology trainees. BMC Nephrology 2018; 19: 14.
  • 13.Reschen ME, Mazzella A, Sharples E. A retrospective analysis of the utility and safety of kidney transplant biopsies by nephrology trainees and consultants. Annals of Medicine and Surgery 2018; 28: 6–10. 14.Lees JS, McQuarrie EP, Mordi N, Geddes CC, Fox JG, Mackinnon B. Risk factors for bleeding complications after nephrologist-performed native renal biopsy. Clinical Kidney Journal 2017; 10(4): 573–77.
  • 15.Ferrer G, Andeen NK, Lockridge J, et al. Kidney Biopsy Adequacy. Am J Surg Pathol 2019; 43: 84–92.
  • 16.Nass K, O’Neill WC. Bedside renal biopsy: ultrasound guidance by the nephrologist. Am J Kidney Dis 1999; 34: 955–59.
  • 17.Korbet SM,Volpini KC, Whittier WL. Percutaneous renal biopsy of native kidneys: A single-center experience of 1,055 biopsies. Am J Nephrol 2014; 39: 153–62.
  • 18.Racusen LC, Solez K, Colvin RB, et al. The Banff 97 working classification of renal allograft pathology Kidney Int 1999; 55(2): 713-23.
  • 19.Geldenhuys L, Nicholson P, Sinha N, et al. Percutaneous native renal biopsy adequacy: a successful interdepartmental quality improvement activity. Can J Kidney Health Dis 2015; 2: 8.
  • 20.Ali H, Murtaza A, Anderton J, Ahmed A. Post renal biopsy complication rate and diagnostic yield comparing hands free (ultrasound-assisted) and ultrasound-guided biopsy techniques of renal allografts and native. SpringerPlus 2015; 4(1): 491.
  • 21.Monahan H, Gunderson T, Greene E, Schmit G, Atwell T, Schmitz J. Risk factors associated with significant bleeding events after ultrasound‑guided percutaneous native renal biopsies: a review of 2204 case. Abdominal Radiology 2019; 44: 2316–32.
  • 22.Shin J, Park SY. Diagnostic efficacy and safety of ultrasound-guided kidney transplant biopsy using cortex-only view: a retrospective single-center study. European Radiology 2019; 29: 5272–79.
There are 16 citations in total.

Details

Primary Language English
Subjects Health and Community Services
Journal Section Surgical Science Research Articles
Authors

Şeyhmus Kaya 0000-0003-4059-9946

Ayhan Şenol 0000-0001-5467-0307

Fatma Şule Kutlar Dursun 0000-0003-3386-6196

Serkan Çelikgün 0000-0003-1825-3113

Early Pub Date June 30, 2023
Publication Date June 30, 2023
Acceptance Date June 23, 2023
Published in Issue Year 2023

Cite

AMA Kaya Ş, Şenol A, Kutlar Dursun FŞ, Çelikgün S. How does the presence of the pathologist affect the tissue adequacy and what are the factors affecting the pathologist in proficiency assessment, during percutaneous kidney biopsy?. CMJ. June 2023;45(2):59-66. doi:10.7197/cmj.1316057